- Home
- AFYA vs IRON Comparison
AFYA vs IRON Comparison
Compare AFYA & IRON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AFYA
- IRON
- Stock Information
- Founded
- AFYA 1999
- IRON 2017
- Country
- AFYA Brazil
- IRON United States
- Employees
- AFYA N/A
- IRON N/A
- Industry
- AFYA Other Consumer Services
- IRON Biotechnology: Pharmaceutical Preparations
- Sector
- AFYA Real Estate
- IRON Health Care
- Exchange
- AFYA Nasdaq
- IRON Nasdaq
- Market Cap
- AFYA 1.6B
- IRON 1.8B
- IPO Year
- AFYA 2019
- IRON N/A
- Fundamental
- Price
- AFYA $15.75
- IRON $57.34
- Analyst Decision
- AFYA Sell
- IRON Strong Buy
- Analyst Count
- AFYA 5
- IRON 11
- Target Price
- AFYA $17.60
- IRON $92.64
- AVG Volume (30 Days)
- AFYA 106.9K
- IRON 397.2K
- Earning Date
- AFYA 08-15-2025
- IRON 08-07-2025
- Dividend Yield
- AFYA 1.55%
- IRON N/A
- EPS Growth
- AFYA 41.32
- IRON N/A
- EPS
- AFYA 1.31
- IRON N/A
- Revenue
- AFYA $599,363,389.00
- IRON N/A
- Revenue This Year
- AFYA $15.52
- IRON N/A
- Revenue Next Year
- AFYA $8.72
- IRON N/A
- P/E Ratio
- AFYA $12.23
- IRON N/A
- Revenue Growth
- AFYA 15.70
- IRON N/A
- 52 Week Low
- AFYA $14.52
- IRON $30.82
- 52 Week High
- AFYA $19.90
- IRON $68.73
- Technical
- Relative Strength Index (RSI)
- AFYA 26.73
- IRON 63.03
- Support Level
- AFYA $17.33
- IRON $52.70
- Resistance Level
- AFYA $18.16
- IRON $58.03
- Average True Range (ATR)
- AFYA 0.43
- IRON 2.45
- MACD
- AFYA -0.18
- IRON 0.28
- Stochastic Oscillator
- AFYA 4.44
- IRON 91.69
About AFYA Afya Limited
Afya Ltd is a medical education group based in Brazil. Its education portfolio has several courses in addition to Medicine, such as Management, Dentistry, Law, Engineering, Nursing, Psychology, and Accounting Sciences, among others. It has three segments; Undergrad provides educational services through undergraduate courses related to medical school, undergraduate health science and other ex-health undergraduate programs, Continuing Education provides medical education, specialization and graduate courses in medicine, delivered through digital and in-person content; and Medical practice solution provides clinical decision, clinical management and doctor-patient relationships for physicians and provide access, demand and efficiency for the healthcare players.
About IRON Disc Medicine Inc.
Disc Medicine Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for hematologic diseases. It aims to modify fundamental biological pathways associated with the formation and function of red blood cells, specifically heme biosynthesis and iron homeostasis. Its pipeline includes bitopertin for erythropoietic porphyrias (EPs) including erythropoietic protoporphyria (EPP), X-linked protoporphyria (XLP), and Diamond-Blackfan Anemia (DBA); DISC-0974 for the treatment of anemia of myelofibrosis (MF) and anemia of chronic kidney disease (CKD); and DISC-3405 for the treatment of polycythemia vera (PV) and other hematologic disorders. In addition, the Company's preclinical programs include DISC-0998.